Quest Diagnostics (DGX) Divestments (2013 - 2016)

Quest Diagnostics (DGX) posted Divestments of $25.0 million for Q4 2016, up 600.0% sequentially from -$5.0 million in Q3 2016.

Quest Diagnostics (DGX) Divestments (2013 - 2016) Analysis & Trends

Quest Diagnostics has reported Divestments for 2 years, with the latest figure at $25.0 million in Q4 2016.

Quarterly Divestments changed N/A year-over-year to $25.0 million in Q4 2016, while the trailing twelve-month figure through Sep 2020 was $25.0 million (changed N/A YoY) and the FY2021 annual result came in at $755.0 million, changed N/A from the prior year.
Divestments rose to $25.0 million in Q4 2016 per DGX's latest filing, from -$5.0 million in the prior quarter.
Over five years, Divestments peaked at $30.0 million in Q3 2013 and troughed at -$5.0 million in Q3 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Thermo Fisher Scientific	213.92 Bn	209.86 Bn	8.34 Bn	-
2	Danaher	140.37 Bn	136.02 Bn	3.61 Bn	-
3	Idexx Laboratories	46.17 Bn	45.97 Bn	779.09 Mn	-
4	Agilent Technologies	39.76 Bn	37.96 Bn	990.00 Mn	-
5	Iqvia Holdings	39.41 Bn	37.33 Bn	1.44 Bn	-
6	Natera	38.75 Bn	37.65 Bn	696.04 Mn	-
7	Illumina	30.07 Bn	28.90 Bn	770.00 Mn	-
8	Mettler Toledo International	28.62 Bn	28.56 Bn	650.22 Mn	-
9	Quest Diagnostics	26.15 Bn	25.53 Bn	1.03 Bn	-
10	Labcorp Holdings	25.87 Bn	24.89 Bn	1.01 Bn	-

Download Data